Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Dublin, Dec. 22, 2016 -- Research and Markets has announced the addition of the "Peripheral Vascular Disease Drugs Price Analysis and Strategies - 2016" report to their offering.
Peripheral Vascular Disease Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Peripheral Vascular Disease market.
The research answers the following questions:
- What are the key drugs marketed for Peripheral Vascular Disease and their clinical attributes? How are they positioned in the Global Peripheral Vascular Disease market?
- What are the unit prices and annual treatment cost for Peripheral Vascular Disease therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
- What are the unmet needs in the global Peripheral Vascular Disease drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Peripheral Vascular Disease?
Research Scope:
- Treatment Options - Identify key drugs marketed and prescribed for Peripheral Vascular Disease including trade name, molecule name, and company
- Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Peripheral Vascular Disease
- Market Positioning - Identify how drugs are clinically and commercially positioned in the global Peripheral Vascular Disease market
- Peripheral Vascular Disease Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
- Find out how the price advanced from 2012 and forecast to 2021
- Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
- Peripheral Vascular Disease New Drug Pricing - Identify the effective pricing strategy for a new drug launch
Key Topics Covered:
1. Treatment Options
2. Drugs Clinical Attributes
3. Drugs Market Positioning
4. Drugs Price Analysis
5. Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
7. Drugs Price Forecast
8. Market Unmet Needs
9. New Drug Pricing
For more information about this report visit http://www.researchandmarkets.com/research/njf6zl/peripheral
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs
